ANRO
Alto Neuroscience, Inc.
NYSE: ANRO · HEALTHCARE · BIOTECHNOLOGY
$25.80
+6.15% today
Updated 2026-04-30
Market cap
$859.49M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.19
Dividend yield
—
52W range
$2 – $28
Volume
0.3M
Alto Neuroscience, Inc. (ANRO) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+11.0%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+13.5%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-12.2%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-15.3%
2025-11-12
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-20 | $-0.45 | +31.8% | $22.04 | $20.02 | -9.2% |
| 2025-11-12 | $-0.52 | +18.8% | $13.40 | $11.35 | -15.3% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.66 | $-0.45 | +31.8% | — | — |
| 2025-09-30 | $-0.64 | $-0.52 | +18.8% | — | — |
| 2025-06-30 | $-0.60 | $-0.65 | -8.3% | — | — |
| 2025-03-31 | $-0.57 | $-0.56 | +1.8% | — | — |
| 2024-12-31 | $-0.55 | $-0.52 | +5.5% | $394000.00 | +5.9% |
| 2024-09-30 | $-0.56 | $-0.62 | -10.7% | — | — |
| 2024-06-30 | $-0.53 | $-0.60 | -13.2% | — | — |
| 2024-03-31 | $-0.46 | $-0.76 | -65.2% | — | — |
| 2023-12-31 | $-1.67 | $-7.77 | -365.3% | $372000.00 | — |
Frequently asked questions
Has Alto Neuroscience, Inc. beaten earnings estimates?
Alto Neuroscience, Inc. has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +11.0% over the last 4 quarters.
How does ANRO stock react to earnings?
ANRO stock has moved an average of -12.2% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.